AU2003222604A1 - Proteins involved in breast cancer - Google Patents

Proteins involved in breast cancer

Info

Publication number
AU2003222604A1
AU2003222604A1 AU2003222604A AU2003222604A AU2003222604A1 AU 2003222604 A1 AU2003222604 A1 AU 2003222604A1 AU 2003222604 A AU2003222604 A AU 2003222604A AU 2003222604 A AU2003222604 A AU 2003222604A AU 2003222604 A1 AU2003222604 A1 AU 2003222604A1
Authority
AU
Australia
Prior art keywords
breast cancer
proteins involved
proteins
involved
breast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003222604A
Other versions
AU2003222604A8 (en
Inventor
Lyndsey J Hudson
Alasdair Craig Stamps
Jonathan Alexander Terrett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Glycosciences UK Ltd
Original Assignee
Oxford Glycosciences UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Glycosciences UK Ltd filed Critical Oxford Glycosciences UK Ltd
Publication of AU2003222604A8 publication Critical patent/AU2003222604A8/en
Publication of AU2003222604A1 publication Critical patent/AU2003222604A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
AU2003222604A 2002-04-11 2003-04-10 Proteins involved in breast cancer Abandoned AU2003222604A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0208331A GB0208331D0 (en) 2002-04-11 2002-04-11 Proteins
GB0208331.9 2002-04-11
PCT/GB2003/001559 WO2003087831A2 (en) 2002-04-11 2003-04-10 Proteins involved in breast cancer

Publications (2)

Publication Number Publication Date
AU2003222604A8 AU2003222604A8 (en) 2003-10-27
AU2003222604A1 true AU2003222604A1 (en) 2003-10-27

Family

ID=9934645

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003222604A Abandoned AU2003222604A1 (en) 2002-04-11 2003-04-10 Proteins involved in breast cancer

Country Status (3)

Country Link
AU (1) AU2003222604A1 (en)
GB (1) GB0208331D0 (en)
WO (1) WO2003087831A2 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005124357A1 (en) * 2004-06-18 2005-12-29 Roche Diagnostics Gmbh Use of protein elongation factor-1-alpha-1 as a marker for breast cancer
US7807789B2 (en) * 2004-12-21 2010-10-05 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in EGFR-signaling pathways
WO2006116541A2 (en) * 2005-04-27 2006-11-02 Caprion Pharmaceuticals, Inc. Tat-002 and methods of assessing and treating cancer
GB0520067D0 (en) * 2005-10-01 2005-11-09 Cancer Rec Tech Ltd Treatment of cancer
GB0611116D0 (en) * 2006-06-06 2006-07-19 Oxford Genome Sciences Uk Ltd Proteins
WO2008005556A2 (en) * 2006-07-07 2008-01-10 9183-4663 Quebec Incorporated Tat-048 and methods of assessing and treating cancer
GB0621279D0 (en) * 2006-10-26 2006-12-06 Nat Blood Service Binding site
FR2919060B1 (en) * 2007-07-19 2012-11-30 Biomerieux Sa METHOD OF DETERMINING EZRINE FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER
FR2919063B1 (en) 2007-07-19 2009-10-02 Biomerieux Sa METHOD OF DETERMINING LEUCOCYTE ELASTASE INHIBITOR FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER.
FR2919061B1 (en) 2007-07-19 2009-10-02 Biomerieux Sa METHOD OF DOSING PLASTINE-I FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER.
US9726670B2 (en) 2007-07-19 2017-08-08 Biomerieux Method for the assay of liver fatty acid binding protein, ACE and CA 19-9 for the in vitro diagnosis of colorectal cancer
FR2919065B1 (en) 2007-07-19 2009-10-02 Biomerieux Sa METHOD FOR DETERMINING APOLIPOPROTEIN AI FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER
FR2919062B1 (en) 2007-07-19 2009-10-02 Biomerieux Sa METHOD OF DETERMINING AMINOACYLASE 1 FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER.
FR2919064B1 (en) 2007-07-19 2009-10-02 Biomerieux Sa METHOD OF ASSAYING APOLIPOPROTEIN ALL FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER
CN101952313B (en) * 2007-11-27 2017-12-15 不列颠哥伦比亚大学 14 33 η antibody and its for diagnose and treatment of arthritis purposes
FR2933773B1 (en) 2008-07-10 2013-02-15 Biomerieux Sa METHOD FOR DETERMINING THE ISOMERASE DISULFIDE PROTEIN FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER
FR2940125B1 (en) 2008-12-23 2013-03-22 Isp Investments Inc COSMETIC OR PHARMACEUTICAL SOOTHING COMPOSITION COMPRISING AN ACTIVATOR PEPTIDE OF HMG-COA REDUCTASE
FR2940291B1 (en) * 2008-12-23 2012-12-21 Isp Investments Inc PEPTIDE DERIVED FROM HMG-COA REDUCTASE AND COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
US11054419B2 (en) 2009-03-11 2021-07-06 Anthony Marotta Compositions and methods for characterizing arthritic conditions
US8933036B2 (en) 2009-04-15 2015-01-13 Isp Investments Inc. Cosmetic and/or pharmaceutical composition comprising a yeast peptide hydrolysate and use of the yeast peptide hydrolysate as an active agent for strengthening hair
FR2944445B1 (en) 2009-04-15 2013-08-16 Isp Investments Inc COSMETIC AND / OR PHARMACEUTICAL COMPOSITION COMPRISING A SOOTHING PEPTIDE HYDROLYZATE
FR2944526B1 (en) 2009-04-15 2013-05-10 Isp Investments Inc COSMETIC AND / OR PHARMACEUTICAL COMPOSITION COMPRISING A PEPTIDE HYDROLYZATE CAPABLE OF STRENGTHENING BARRIER FUNCTION
EP3144394B1 (en) * 2010-12-08 2019-02-06 Expression Pathology, Inc. Truncated her2 srm/mrm assay
AU2012325604B2 (en) 2011-10-21 2017-08-03 Augurex Life Sciences Corp. Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis
ES2526468B2 (en) * 2013-06-07 2015-08-07 Universidad Complutense De Madrid Method of selection of specific antibodies of European hake (Merluccius merluccius) to assign individuals to their populations according to whether they are of Atlantic origin or of Mediterranean origin.
GB201520568D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520546D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
US10537576B2 (en) 2015-12-09 2020-01-21 Expression Pathology, Inc. Methods for treating Her2-positive breast cancer
IT202000016807A1 (en) * 2020-07-10 2022-01-10 Humanitas Mirasole Spa PEPTIDES ASSOCIATED WITH CANCER AND THEIR USE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS626169A (en) * 1985-07-03 1987-01-13 Mochida Pharmaceut Co Ltd Reagent for diagnosing cancer
GB0004576D0 (en) * 2000-02-25 2000-04-19 Oxford Glycosciences Uk Ltd Proteins
BR0108659A (en) * 2000-02-25 2002-11-05 Oxford Glycosciences Methods for treatment or prevention or prophylaxis of breast cancer, for detection, diagnosis and / or assessment or prognosis for breast cancer, for monitoring and / or estimation of breast cancer treatment, for identifying the presence or absence of breast cells metastatic breast cancer in a biological sample and for the evaluation or identification of compounds, uses of one or more bcmps, a composition, an antibody, nucleic acid and an agent that interacts with or modulates the activity of one or more bcmps , vaccine, composition, kit and antibody

Also Published As

Publication number Publication date
AU2003222604A8 (en) 2003-10-27
WO2003087831A2 (en) 2003-10-23
WO2003087831A3 (en) 2004-07-29
GB0208331D0 (en) 2002-05-22

Similar Documents

Publication Publication Date Title
AU2003222604A1 (en) Proteins involved in breast cancer
AU2003214626A1 (en) Breast cancer screening
AU2003215460A1 (en) Cancer associated protein kinases and their uses
AU2003227861A1 (en) Protein involved in cancer
AU2003212162A1 (en) Cancer associated protein phosphatases and their uses
AU2002362613A1 (en) Galectins-1-and-4 in tumor development
AU2003226899A1 (en) Human diabetes-mediating proteins
AU2001288921A1 (en) Human breast cancer biomarkers
AU2002249221A1 (en) Use of casb7439 (ash2) in the immunotherapy of breast cancer
AU2003283339A1 (en) Cancer therapy determination
AU2002360815A1 (en) Human breast cancer biomarkers
AU2003202694A1 (en) Torero protein
GB0230111D0 (en) Protein involved in breast cancer
AU2003267805A1 (en) Brassiere
AU2003270055A1 (en) Neurotransmission-associated proteins
AU2003278718A1 (en) Stars-a muscle-specification-binding protein
GB0229875D0 (en) Protein involved in cancer
AU2002363807A1 (en) Breast cancer associated polypeptide
AU2003252034A1 (en) Genes differentially expressed in breast cancer
AU2003300785A1 (en) Carbohydrate-associated proteins
GB0219778D0 (en) Protein involved in colorectal cancer
GB0308327D0 (en) A protein involved in cancer
GB0305342D0 (en) Protein folding in cancer
GB0305387D0 (en) Protein stability and cancer
AU2003236908A1 (en) Proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase